Vanguard Fiduciary Trust
XFOR icon

Vanguard Fiduciary Trust’s X4 Pharmaceuticals XFOR Stock Holding History

Vanguard Fiduciary Trust’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67M Buy
572,038
+91,305
+19% +$375K ﹤0.01% 2520
2026
Q1 		$1.99M Buy
+480,733
New +$1.8M ﹤0.01% 2575

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $140M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust's XFOR Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its X4 Pharmaceuticals (XFOR) stake by 19% in Q2 2026, buying an estimated $375K and bringing the position to 572,038 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2520.

Vanguard Fiduciary Trust first reported a position in XFOR in Q1 2026 and has held it in 2 quarters since. 88 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Vanguard Fiduciary Trust held 572,038 shares of X4 Pharmaceuticals worth $2.67M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 91,305 X4 Pharmaceuticals shares in Q2 2026, an estimated $375K.
  • X4 Pharmaceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2520 holding.
  • Vanguard Fiduciary Trust first reported a position in X4 Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 88 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.